coronavirus-infections

Documents about coronavirus-infections

• The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?#852862ClinicalTrials.gov
• Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis#967803ClinicalTrials.gov
• In silico analysis of C₆₀ fullerene interaction with TMPRSS2: toward novel COVID-19 prevention approaches#463859Dbt
• Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above#373648ClinicalTrials.gov
• Pandemic research in a small island society-a narrative review of research contributions during the SARS-CoV-2 pandemic in the Faroe Islands.#646482PubMed
• Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)#870084ClinicalTrials.gov
• Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above#356538ClinicalTrials.gov
• A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers#981074ClinicalTrials.gov
• Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients#994511ClinicalTrials.gov
• This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19#982427ClinicalTrials.gov